Mytos raises $19M Series A to boost cell manufacturing system market presence news2023-11-30T13:00:44+00:00November 30th, 2023|Endpoints News|
Breaking: AbbVie to acquire ImmunoGen for $10B in banner year for ADCsnews2023-11-30T12:54:23+00:00November 30th, 2023|Endpoints News|
Exclusive: Novo foundation’s growth arm is making an investment push into healthcare, expanding beyond life sciencesnews2023-11-30T12:32:44+00:00November 30th, 2023|Endpoints News|
CRO Fortrea ‘disputes the accuracy’ of Acelyrin’s claims about immunology drug trial conductnews2023-11-30T12:22:39+00:00November 30th, 2023|Endpoints News|
Luke Miels on GSK internal changes, ‘very busy’ BD scenenews2023-11-30T12:18:07+00:00November 30th, 2023|Endpoints News|
Xenon offers $300M in shares after touting path ahead for MDD program despite PhII missnews2023-11-30T12:08:28+00:00November 30th, 2023|Endpoints News|
Orna Therapeutics trims staff in ‘defensive reduction’ despite large financing haulsnews2023-11-30T11:36:55+00:00November 30th, 2023|Endpoints News|
Clinicians say benefits of CAR-T continue to outweigh risk of T-cell malignanciesnews2023-11-29T20:53:02+00:00November 29th, 2023|Endpoints News|
Health tech stands out as a top area for early-stage VC funding in Q3news2023-11-29T20:33:45+00:00November 29th, 2023|Endpoints News|
Senate Finance Committee to review federal policies on drug shortagesnews2023-11-29T20:15:46+00:00November 29th, 2023|Endpoints News|
